Breakthrough Study Reveals Connexin 43’s Role in Triple-Negative Breast Cancer
Recent research led by Dr. Yun Fu from the Department of Breast Surgery at the Shanghai Institute of Maternal-Fetal Medicine has unveiled significant insights into the role of connexin 43 (Cx43) in triple-negative breast cancer (TNBC). Published in S
Breakthrough Study Reveals Connexin 43’s Role in Triple-Negative Breast Cancer Read More »